1-cyclopropyl-3-(3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl)urea,
AT 9283,
AT-9283,
AT9283,
AT9283,
896466-04-9,
1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea,
AT-9283,
UNII-XAV9KYN9WL,
AT 9283,
XAV9KYN9WL,
J-504568,
C19H23N7O2,
1-cyclopropyl-3-(3-(6-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea,
1-Cyclopropyl-3-{3-[5-(Morpholin-4-Ylmethyl)-1h-Benzimidazol-2-Yl]-1h-Pyrazol-4-Yl}urea,
3-cyclopropyl-1-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}urea,
35R,
896466-76-5,
cc-56,
MLS006011044,
SCHEMBL545809,
CHEMBL495727,
GTPL7949,
SCHEMBL15005492,
SCHEMBL15005494,
BDBM27087,
CTK8C2842,
KS-00001DTX,
EX-A201,
SYN1011,
CHEBI:125514,
LOLPPWBBNUVNQZ-UHFFFAOYSA-N,
BCPP000379,
HMS3244O09,
HMS3244O10,
HMS3244P09,
HMS3654G08,
BCP11714,
ANW-69120,
MFCD12031513,
RS0013,
s1134,
ZINC34637502,
ZINC38995988,
AKOS016006006,
AKOS026750645,
ZINC136047369,
BCP9000337,
CS-0107,
QC-4297,
Urea, N-cyclopropyl-N'-(3-(6-(4-morpholinylmethyl)-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl)-,
NCGC00346493-01,
NCGC00346493-06,
pyrazole-benzimidazole urea analogue, 16,
AJ-97300,
AK-43760,
AS-16186,
BC659956,
HY-50514,
SMR004702836,
AB0033752,
AX8211351,
DB-078462,
SW220119-1,
X7478,
W-5568,
466C049,
BRD-K24576554-001-01-4,
AT-9283, AT 9283, 896466-04-9,
1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1h-benzoimidazol-2-yl )-1h-pyrazol-4-yl]-urea,
1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea,
N-cyclopropyl-N'-[3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]Urea,
1-cyclopropyl-3-[(3E)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea,
1-cyclopropyl-3-[(3Z)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea,
D05PZB,
VRXXZJLHPWWXIX-ISLYRVAYSA-N,
CID11496629,
CID11696609,
CID 11496629,
A4117,
A10095,